You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Prostanoids for intermittent claudication
|
---|---|
Published in |
Cochrane database of systematic reviews, April 2013
|
DOI | 10.1002/14651858.cd000986.pub3 |
Pubmed ID | |
Authors |
Lindsay Robertson, Alina Andras |
Abstract |
Peripheral arterial disease (PAD) is a common cause of morbidity in the general population. While numerous studies have established the efficacy of prostanoids in PAD stages III and IV, the question of the role of prostanoids as an alternative or additive treatment in patients suffering from intermittent claudication (PAD II) has not yet been clearly answered. This is an update of a Cochrane Review first published in 2004. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Japan | 1 | 25% |
Egypt | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 209 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Finland | 1 | <1% |
Denmark | 1 | <1% |
Sri Lanka | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 205 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 27 | 13% |
Student > Bachelor | 27 | 13% |
Researcher | 26 | 12% |
Student > Ph. D. Student | 19 | 9% |
Other | 10 | 5% |
Other | 35 | 17% |
Unknown | 65 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 81 | 39% |
Nursing and Health Professions | 20 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
Psychology | 6 | 3% |
Social Sciences | 5 | 2% |
Other | 23 | 11% |
Unknown | 67 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2020.
All research outputs
#7,077,903
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,164
of 11,499 outputs
Outputs of similar age
#55,930
of 204,400 outputs
Outputs of similar age from Cochrane database of systematic reviews
#173
of 249 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,400 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 249 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.